Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
76-90 of 1732 results
Emisphere, Novo Nordisk to develop four oral formulations using Eligen technology
By PBR Staff Writer
Emisphere Technologies and Novo Nordisk have entered into an agreement to develop and commercialize oral formulations of four molecules for metabolic disorders.
Automation > IT & Software > News
Sphaera Pharma receives notice of allowance from USPTO for drug modification platform technology
Sphaera Pharma has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its Patent application titled ‘Substituted methylformyl reagents and method of using same to modify physicochemical and/ or pharmacokinetic properties of compounds’, for its platform technology.
Automation > IT & Software > News
Astellas signs deal with Immunomic Therapeutics for worlwide license of LAMP-vax
By PBR Staff Writer
Japan-based Astellas Pharma has signed a deal with the US biotechnology firm Immunomic Therapeutics for an exclusive worldwide license of LAMP-vax products, developed to treat or prevent any allergic diseases in humans.
Automation > IT & Software > News
Symplmed, PuraCap Pharmaceutical team up to distribute new EpiCeram-L Lip Care
Symplmed has entered into an agreement with PuraCap Pharmaceutical to distribute a new product, EpiCeram-L Lip Care, through Symplmed’s patented DyrctAxess technology.
Automation > IT & Software > News
GSK exercises option for inhaled therapeutics from Liquidia Technologies
By PBR Staff Writer
GlaxoSmithKline (GSK) has exercised an option that gives it the exclusive rights to research, develop and commercialize inhaled therapeutics derived from Liquidia Technologies' PRINT technology.
Automation > IT & Software > News
Illumina introduces TruSight Tumor 15 panel
Illumina has launched TruSight Tumor 15, a next-generation sequencing (NGS) panel designed to identify sequence variants in 15 genes commonly associated with marketed therapeutics.
Automation > IT & Software > News
PCORI approves $83m for hepatitis C and other studies
By PBR Staff Writer
The Patient-Centered Outcomes Research Institute (PCORI) has approved $83m to fund 26 patient-centered, comparative clinical effectiveness research (CER) studies on a range of conditions and patient populations.
Automation > IT & Software > News
Eli Lilly and Sanofi settle Basaglar insulin product lawsuit
By PBR Staff Writer
Eli Lilly and Company has entered into a settlement agreement to resolve patent litigation with Sanofi over its Basaglar insulin glargine product.
Automation > IT & Software > News
Syros Pharmaceuticals licenses clinical-stage RARa agonist
Syros Pharmaceuticals has entered into an exclusive license agreement with the Japanese oncology company TMRC, to develop and commercialize tamibarotene in North America and Europe for cancer.
Automation > IT & Software > News
ERYTECH Pharma wins US patent for erythrocytes containing arginine deiminase
ERYTECH Pharma announced the issuance of a new patent in the US.
Automation > IT & Software > News
BioClinica acquires Synowledge
BioClinica has acquired Synowledge to expand its offering into the growing drug safety and regulatory business process outsourcing market.
Automation > IT & Software > News
AstraZeneca to release preclinical data from over 50 medicines for cancer drug development
By PBR Staff Writer
AstraZeneca said it will release preclinical data from more than 50 of its medicines as part of the DREAM Challenge, to develop cancer drug through crowd sourcing.
Automation > IT & Software > News
UB spinoff Cytocybernetics tests new biotechnology to enhance drug safety screening
By PBR Staff Writer
A spin off company of University at Buffalo (UB), Cytocybernetics is testing a new biotechnology to enhance drug safety screening.
Automation > IT & Software > News
M Pharmaceutical to request DTC eligibility to enhance liquidity on OTCQB
M Pharmaceutical will engage a participant of the Depository Trust Company (DTC) to request that its securities become eligible for depository services.
Automation > IT & Software > News
Cell Signaling Technology releases VISTA rabbit monoclonal antibody
Cell Signaling Technology (CST) has released a IHC-approved, human-specific, VISTA rabbit monoclonal antibody (mAb), for use in biomedical research.
Automation > IT & Software > News
76-90 of 1732 results